MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1
Open Access
- 18 May 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 75844-75853
Abstract
MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1 MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1Keywords
This publication has 27 references indexed in Scilit:
- MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathwaysBritish Journal of Cancer, 2015
- MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis, and Prognosis by Targeting CDC6 in Lung CancerMolecular Cancer Research, 2014
- The Antifibrotic Effects and Mechanisms of MicroRNA-26a Action in Idiopathic Pulmonary FibrosisMolecular Therapy, 2014
- Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosisCell Death & Disease, 2014
- MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet PathwayHepatology, 2013
- MicroRNA-663 Regulates Human Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Neointimal FormationCirculation Research, 2013
- MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-cateninGastroenterology, 2012
- The role of microRNAs in arterial remodellingThrombosis and Haemostasis, 2012
- MicroRNA‐26a is a novel regulator of vascular smooth muscle cell functionJournal of Cellular Physiology, 2010
- PDGF signaling in cells and miceCytokine & Growth Factor Reviews, 2004